PDF GEL 1.24% 1.24 %
FLUORINE (SODIUM FLUORIDE) : 1.24 % HYDROGEN FLUORIDE : 3.5 MG · DIN 00461024 · LAB BMG INC.
Health Canada status: CANCELLED POST MARKET
What is PDF GEL 1.24%?
PDF GEL 1.24% 1.24 % contains FLUORINE (SODIUM FLUORIDE) : 1.24 % HYDROGEN FLUORIDE : 3.5 MG. It is listed in the Health Canada Drug Product Database under DIN 00461024, held by LAB BMG INC., supplied as GEL for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Aug-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00461024 |
|---|---|
| Brand name | PDF GEL 1.24% |
| Generic / active ingredient | FLUORINE (SODIUM FLUORIDE) : 1.24 % HYDROGEN FLUORIDE : 3.5 MG |
| Manufacturer | LAB BMG INC. |
| Strength | 1.24 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A01AA30 COMBINATION (CARIES PROPHYLACTIC AGENTS) |
| AHFS class | 34:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Aug-1998 |
| Original market date | 1980-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A01AA30 COMBINATION (CARIES PROPHYLACTIC AGENTS). 0 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACIDULATED PHOSPHATE FLUORIDE ORAL SOLUTION | .017 % | SOLUTION | PDT IMAGE INC. DBA PRO-DENTEC CANADA | CANCELLED POST MARKET | DIN 02117339 |
| PASCAL PUFF | 1.23 % | LIQUID | PASCAL INTERNATIONAL CORPORATION | CANCELLED POST MARKET | DIN 02241675 |
| PERFECT CHOICE 0.717% ROOT AND DENTIN DESENS | .14 % | LIQUID | CHALLENGE PRODUCTS INC. | CANCELLED POST MARKET | DIN 02044951 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.